Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral and gastrointestinal pathogenic bacteria collectively refers to a diverse group of bacterial species capable of causing disease in the oral cavity (e.g., Streptococcus mutans, Porphyromonas gingivalis) and gastrointestinal tract (e.g., Salmonella enterica, Shigella, Campylobacter jejuni, Escherichia coli pathotypes, Helicobacter pylori). These organisms may be commensals in healthy individuals but become opportunistic pathogens under certain conditions, or are exogenous pathogens that invade and colonize mucosal surfaces. This group encompasses Gram-positive and Gram-negative bacteria, aerobes, anaerobes, and a variety of taxonomic groups. They contribute to diseases such as gastroenteritis, food poisoning, peptic ulcers, periodontitis, and systemic infections. Therapies are usually broad-spectrum or targeted antibiotics and, in some cases, vaccines or microbial interventions, but increasing antimicrobial resistance is a major safety concern[1][2][3][4].
Inhibition of cell wall synthesis (β-lactams, vancomycin); Inhibition of protein synthesis (macrolides, tetracyclines); Inhibition of DNA replication (fluoroquinolones); Disruption of cell membrane (polymyxins); Neutralization of toxins; Microbiota modulation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral and gastrointestinal pathogenic bacteria (null).